Dana-Farber Cancer Institute and Sanford-Burnham Medical Research Institute have signed a license agreement with Genentech, Inc. and Read More >>

NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of Read More >>

Research and Markets (http://www.researchandmarkets.com/research/952c19/the_biotech_compan) has announced the addition of the "The Biotech Company Read More >>

Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for Read More >>

Research and Markets(http://www.researchandmarkets.com/research/aaf0d1/stakeholder_insigh) has announced the addition of the "Stakeholder Insight: Read More >>

ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products using its antibody expertise and T Read More >>

SurModics, a provider of drug delivery and surface modification technologies, has opened a new facility for manufacturing and development in Birmingham, Ala Read More >>

Having stepped up lifecycle management for its leading breast cancer monoclonal antibody, Herceptin, Roche hopes to encourage uptake of a more convenient fo Read More >>

Silicon Valley is slipping as a place to work -- judged, at least, by the ranking of employers on Fortune Read More >>

Silicon Valley is slipping as a place to work -- judged, at least, by the ranking of employers on Fortune Read More >>

CED has announced the slate of speakers scheduled for CED's Biotech 2010 conference, to be held Feb. 22 through Feb. 23 at the Read More >>

Osi Pharmaceuticals, and Genentech, a wholly owned member of the Roche Group, have reported that the FDA has extended the review period for the supplemental Read More >>

OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) and Genentech, Inc., a wholly owned member of the Roche Group (SIX Read More >>

Genentech, a wholly owned member of the Roche Group, has reported that the FDA approved Actemra for the treatment of adult patients with moderately to sever Read More >>

Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Three deals dominated the drug industry this year: Each of th Read More >>

Genentech, Inc., a wholly owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and D Read More >>